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COMPARISON OF OSTEOARTHRITIS AND NORMAL HIP CARTILAGE
TRANSCRIPTOMES USING RNA-SEQ REVEALS NEW CANDIDATE
GENE TARGETS AND ASSOCIATED PATHWAYS
Y. Xu, M.J. Barter, D.C. Swan, K.S. Rankin, A.D. Rowan, M. Santibanez-
Koref, J. Loughlin, D.A. Young. Newcastle Univ., Newcastle upon Tyne,
United Kingdom
Purpose: Osteoarthritis (OA) is the most prevalent joint disease, leading
to progressive degradation of the articular cartilage. To investigate
precise molecular changes occurring in the cartilage during disease
development, we used RNA sequencing (RNA-seq) to compare the
transcriptome of OA and normal hip cartilage. Based on Next Genera-
tion DNA sequencing technology, RNA-seq is not only able to determine
gene expression levels genome-wide but can also identify alternative
splicing events, new classes of RNA and single nucleotide poly-
morphisms (SNPs). Here we have focused on expression analysis.
Methods: Total RNA was isolated from human articular cartilage
samples obtained from consented patients undergoing joint replace-
ment surgery due to either end-stage hip OA or neck of femur fracture
(NOF). 78-base paired-end sequencing was performed on an Illumina
Genome Analyzer IIx according to the manufacturer's protocol.
Sequencing reads were ﬁltered to trim low quality ends before aligning
them to known human genome transcript sequences using Novocraft
Novoalign. Bioconductor package cqn was used to normalize read
counts and minimize bias due to gene length and GC content. Samples
were clustered according to their expression proﬁles to check quality of
RNA samples and differentially expressed genes were identiﬁed using
Bioconductor package edgeR. Function and pathway analyses were
performed with the Ingenuity Pathway Analysis package. The results
were compared and veriﬁed using the results from whole-genome
microarray experiments.
Results: On average, 54 million 78-base pair-end reads were produced
for RNAs from each OA (n¼10) and NOF (n¼6) cartilage sample. At least
26% of transcripts in each sample had a coverage depth 0.9. Clear
separation of OA and NOF samples in the hierarchical clustering result
indicated the reliability of the expression proﬁles. In total, 1434 genes
(P-values0.01, fold change -2 or 2) were identiﬁed as differentially
expressed. Changes in the expression of these genes signiﬁcantly
correlated with equivalent changes in traditional microarray hybrid-
ization experiments (r ¼ 0.84) but revealed novel associations with
a number of canonical pathways, such as IL-6 (P-value¼0.00036),
HMGB1 (P-value¼0.001), toll-like receptor (P-value¼0.013) and BMP
(P-value¼0.044) signaling.
Conclusions: This is the ﬁrst application of RNA-seq to investigate OA
cartilage. Transcriptomes obtained with this method have excellent
correlation with expression data from a microarray platform but also
show improved sensitivity and the ability to detect a wider range of
expression changes. This has allowed us to identify a number of addi-
tional pathogenic pathways associated with OA. With conﬁrmation of
the quality and reliability of the RNA-seq data, we will proceed to
determine alternative splicing events, novel RNAs and other post-
transcriptional events.
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SUBSTANTIAL ALTERATION OF POST-TRANSCRIPTIONAL GENE
CONTROL IN CHONDROCYTES FROM OSTEOARTHRITIC JOINTS
S.R. Tew, B. McDermott, O. Vasieva, P.D. Clegg. Univ. of Liverpool,
Liverpool, United Kingdom
Purpose: Regulation of mRNA decay rates offers cells a means of
controlling not only gene expression levels but also gene responsive-
ness to altered transcriptional input. We have previously shown that
important chondrocyte markers such as SOX9 and COL2A1 can be
controlled post-transcriptionally in chondrocytes if exposed to cell
stresses such as hyperosmolarity. Interestingly, recent evidence shows
that molecules that are known to control mRNA decay, such as micro-
RNAs, are regulated during osteoarthritis (OA). In this studywe aimed to
determine, for the ﬁrst time, the effect of OA pathology on the rates of
mRNA decay across the chondrocyte transcriptome.
Methods: Human articular chondrocytes (HAC) were isolated from
normal cartilage (N), macroscopically intact OA tissue (I) or macro-
scopically degenerate OA tissue (D) and used within 24 hours. An
osteochondral sample from each specimen was collected to allow
histological grading. RNA decay was measured using microarrayanalysis of HAC total RNA, which was collected 0, 1, 3 and 5 hours after
treatment of the HAC with the transcription inhibitor actinomycin D.
Transcriptome-wide mRNA half-lives were determined by linear
regression and signiﬁcant differences between the rates observed in
different tissue sources was determined using student's t-test with false
discovery rate testing. Gene ontology investigations were carried out
using Ingenuity Pathway Analysis (IPA).
Results: Initial examination of total mRNA expression levels (using the
time 0 values of the decay curves) demonstrated signiﬁcant differences
in the expression of transcripts between normal and osteoarthritic
cartilage (N vs. I and N vs. D), which in many instances involved regu-
lation of the same genes. Interestingly, we found almost no signiﬁcant
difference in total mRNA expression between chondrocytes isolated
from either intact vs. degenerate OA cartilage (I vs. D). Subsequent
examination of the half-life of mRNA in chondrocytes from these
different tissues also showed greater variation between the normal
chondrocytes and the OA chondrocytes. However, in contrast to total
RNA analysis, we detected high numbers of signiﬁcantly regulated genes
in comparisonsbetweeneverygroup. (Nvs. I¼592,Nvs.D¼417, I vs.D¼
361). Despite demonstrating altered post-transcriptional control, most
of these genes did not display overall regulation at their transcript level.
Examination of the post-transcriptionally regulated genes using IPA
indicated that pathways such as NFkB and JAK/STAT were affected
through altered post-transcriptional control in OA, as well as pathways
controlling cell cycle, apoptosis and extracellular matrix synthesis.
Conclusions: The surprising ﬁnd of this study is the large number of
transcripts whose decay rates are altered in osteoarthritis; greater than
the number of genes whose overall expression was regulated. These
changes, despite the unchanged steady state expression of these genes
in health and disease, provides evidence that OA substantially affects
the regulatory dynamics that underpin gene expression levels and
could consequently alter the genes’ response to transcriptional stim-
ulus. This might play an important role in the development and
progression of OA pathology.
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INHIBITION OF WNT/B-CATENIN PATHWAY BY SCLEROSTIN
PROMOTES CARTILAGE MAINTENANCE
W. Bouaziz, T. Funk-Brentano, H. Lin, E. Hay, M. Cohen-Solal. INSERM606,
Paris, France
Purpose: Cartilage homeostasis is regulated by several mechanisms
that inﬂuence both anabolic and catabolic balance. Among them, the
local activation of Wnt pathways plays a major role in chondrocyte
activity which might be regulated by Wnt inhibitors. Sclerostin, a Wnt
inhibitor mainly produced by osteocytes and hypertrophic chon-
drocytes, might participate to the crosstalk between bone and cartilage.
Therefore, the aim of this study is to determine the effect of Sclerostin in
chondrocyte function.
Methods: Primary murine chondrocytes, isolated from long bone
epiphysis of 6 day-old mice, were cultured with or without Wnt3a
conditionedmedia (Wnt3aCM) and in the presence or absence ofmouse
recombinant Sclerostin. Proteoglycan release induced by Wnt was
quantiﬁed in the supernatant of chondrocytes by a colorimetric assay.
Activation and inhibition of Wnt pathway was shown by the trans-
location of b-catenin (IF, TOP-GAL activity). BrdU and Tunel assays were
performed to test the effect of Wnt and Sclerostin on cell proliferation
and apoptosis. Chondrocyte differentiation induced by Sclerostin was
investigated by RT-qPCR through the relative expression of type II and X
collagen, Sox9, aggrecan, MMP-3, MMP-13 ADAMTS-4 & 5 genes.
Results: Wnt3aCM reduced proteoglycan release in a dose-dependent
manner and was rescued by Sclerostin (20ng/ml). This dose was chosen
for the following experiments. Wnt inhibited the gene expression of
collagen type II (X18-fold), Sox9 (X140 fold) and Aggrecan (X90-fold) and
increases the gene expression of metalloproteinases such as Adamts-4
(X5-fold), Adamts-5 (X5.5-fold), MMP3 (X7-fold) and MMP13 (X6.6-
fold). Sclerostin was able to inhibit the nuclear translocation of b-catenin
induced by Wnt, but failed to exert any effect in the proliferation or
apoptosis in primary chondrocytes regardless of Wnt. However, Wnt3a
increased the gene expression of collagen type X (X3-fold) which was
abolished by Sclerostin (X1.6-fold). Sclerostin signiﬁcantly inhibited the
Wnt-induced increase of catabolic genes (X1.7-fold Adamts-4, X1.6-fold
Adamts-5, X3.4-fold MMP3 and X4-fold MMP13) and rescues partially
the expression of anabolic genes (X5- fold collagen type II, X6-fold Sox-9
and X11-fold Aggrecan). In addition, Wnt3a induced the expression of
